FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509812236> ?p ?o ?g. }

• W2509812236 abstract "Improved outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention remain an unmet clinical need. We assessed the long-term efficacy and safety of novel polymer-free sirolimus- and probucol-eluting stent in diabetic patients enrolled in intracoronary stenting and angiographic results: test efficacy of sirolimus- and probucol-eluting versus zotarolimus-eluting stents 5 trial. In a pre-specified subgroup analysis, outcomes of diabetic patients treated with a sirolimus- and probucol-eluting stent or a second-generation zotarolimus-eluting stent were compared. The primary endpoint was a device-oriented composite outcome comprising cardiac death, target vessel-related myocardial infarction (MI), or target lesion revascularization (TLR) at 5-year follow-up. Event-free survival was assessed using the Kaplan–Meier method. Hazard ratios (HR) and 95 % confidence intervals (CI) were estimated from univariate Cox proportional hazards models. A total of 870 patients with diabetes mellitus were treated with either a sirolimus- and probucol-eluting stent (n = 575) or a second-generation zotarolimus-eluting stent (n = 295). At 5 years, the rate of device-oriented composite endpoint was comparable between the sirolimus- and probucol-eluting stent and the second-generation zotarolimus-eluting stent (32.9 versus 33.4 %, HR 0.88, 95 % CI 0.76–1.26). No significant differences were observed between the sirolimus- and probucol-eluting stent and the second-generation zotarolimus-eluting stent groups in the incidence of cardiac death (15.6 versus 16.7 % HR 0.92, 95 % CI 0.63–1.32), target-vessel MI (4.6 versus 6.6 %, HR 0.73, 95 % CI 0.40–1.34), and TLR (18.6 versus 18.8 %, HR 1.00, 95 % CI, 0.72–1.41). The rate of definite or probable stent thrombosis was low and similar in both groups (2.5 versus 2.6 %, HR 1.02, 95 % CI, 0.41–2.52). In patients with diabetes the long-term efficacy and safety of a polymer-free sirolimus- and probucol-eluting stent were comparable to a second-generation durable polymer zotarolimus-eluting stent. Trial registration ClinicalTrials.gov NCT00598533. Registered 10 January 2008" @default.
• W2509812236 created "2016-09-16" @default.
• W2509812236 creator A5015669756 @default.
• W2509812236 creator A5023287828 @default.
• W2509812236 creator A5024459238 @default.
• W2509812236 creator A5043660785 @default.
• W2509812236 creator A5062328676 @default.
• W2509812236 creator A5066812477 @default.
• W2509812236 creator A5068482307 @default.
• W2509812236 creator A5072855917 @default.
• W2509812236 creator A5081118195 @default.
• W2509812236 creator A5086795617 @default.
• W2509812236 creator A5091776005 @default.
• W2509812236 date "2016-09-01" @default.
• W2509812236 modified "2023-09-25" @default.
• W2509812236 title "Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial" @default.
• W2509812236 cites W146601392 @default.
• W2509812236 cites W1527614413 @default.
• W2509812236 cites W1592199073 @default.
• W2509812236 cites W167221777 @default.
• W2509812236 cites W176420385 @default.
• W2509812236 cites W1907383094 @default.
• W2509812236 cites W1966714873 @default.
• W2509812236 cites W1969081971 @default.
• W2509812236 cites W1978136073 @default.
• W2509812236 cites W2015132580 @default.
• W2509812236 cites W2026744581 @default.
• W2509812236 cites W2030235211 @default.
• W2509812236 cites W2037298051 @default.
• W2509812236 cites W2091723136 @default.
• W2509812236 cites W2095508172 @default.
• W2509812236 cites W2096098042 @default.
• W2509812236 cites W2101117563 @default.
• W2509812236 cites W2107233004 @default.
• W2509812236 cites W2108577293 @default.
• W2509812236 cites W2119470649 @default.
• W2509812236 cites W2129349488 @default.
• W2509812236 cites W2132037627 @default.
• W2509812236 cites W2163231121 @default.
• W2509812236 cites W2167788046 @default.
• W2509812236 cites W2168008786 @default.
• W2509812236 cites W2226144646 @default.
• W2509812236 cites W2307015938 @default.
• W2509812236 cites W35721928 @default.
• W2509812236 doi "https://doi.org/10.1186/s12933-016-0429-y" @default.
• W2509812236 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5009646" @default.
• W2509812236 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27586678" @default.
• W2509812236 hasPublicationYear "2016" @default.
• W2509812236 type Work @default.
• W2509812236 sameAs 2509812236 @default.
• W2509812236 citedByCount "13" @default.
• W2509812236 countsByYear W25098122362017 @default.
• W2509812236 countsByYear W25098122362018 @default.
• W2509812236 countsByYear W25098122362019 @default.
• W2509812236 countsByYear W25098122362021 @default.
• W2509812236 countsByYear W25098122362023 @default.
• W2509812236 crossrefType "journal-article" @default.
• W2509812236 hasAuthorship W2509812236A5015669756 @default.
• W2509812236 hasAuthorship W2509812236A5023287828 @default.
• W2509812236 hasAuthorship W2509812236A5024459238 @default.
• W2509812236 hasAuthorship W2509812236A5043660785 @default.
• W2509812236 hasAuthorship W2509812236A5062328676 @default.
• W2509812236 hasAuthorship W2509812236A5066812477 @default.
• W2509812236 hasAuthorship W2509812236A5068482307 @default.
• W2509812236 hasAuthorship W2509812236A5072855917 @default.
• W2509812236 hasAuthorship W2509812236A5081118195 @default.
• W2509812236 hasAuthorship W2509812236A5086795617 @default.
• W2509812236 hasAuthorship W2509812236A5091776005 @default.
• W2509812236 hasBestOaLocation W25098122361 @default.
• W2509812236 hasConcept C126322002 @default.
• W2509812236 hasConcept C126894567 @default.
• W2509812236 hasConcept C141071460 @default.
• W2509812236 hasConcept C164705383 @default.
• W2509812236 hasConcept C168563851 @default.
• W2509812236 hasConcept C203092338 @default.
• W2509812236 hasConcept C207103383 @default.
• W2509812236 hasConcept C2776167589 @default.
• W2509812236 hasConcept C2777546689 @default.
• W2509812236 hasConcept C2777921159 @default.
• W2509812236 hasConcept C2778163477 @default.
• W2509812236 hasConcept C2778583881 @default.
• W2509812236 hasConcept C2780400711 @default.
• W2509812236 hasConcept C2780797203 @default.
• W2509812236 hasConcept C44249647 @default.
• W2509812236 hasConcept C500558357 @default.
• W2509812236 hasConcept C71924100 @default.
• W2509812236 hasConceptScore W2509812236C126322002 @default.
• W2509812236 hasConceptScore W2509812236C126894567 @default.
• W2509812236 hasConceptScore W2509812236C141071460 @default.
• W2509812236 hasConceptScore W2509812236C164705383 @default.
• W2509812236 hasConceptScore W2509812236C168563851 @default.
• W2509812236 hasConceptScore W2509812236C203092338 @default.
• W2509812236 hasConceptScore W2509812236C207103383 @default.
• W2509812236 hasConceptScore W2509812236C2776167589 @default.
• W2509812236 hasConceptScore W2509812236C2777546689 @default.
• W2509812236 hasConceptScore W2509812236C2777921159 @default.
• W2509812236 hasConceptScore W2509812236C2778163477 @default.
• W2509812236 hasConceptScore W2509812236C2778583881 @default.
• W2509812236 hasConceptScore W2509812236C2780400711 @default.
• W2509812236 hasConceptScore W2509812236C2780797203 @default.

• next